Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Plasma Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00169559
What this trial is testing

Dyslipidemia Study Investigating The Increase In "Good Cholesterol"

Who this might be right for
Dyslipidaemias
GlaxoSmithKline 250
Testing effectiveness (Phase 2)Study completedNCT01283997
What this trial is testing

Prevention of Treatment Induced Neuropathy in Multiple Myeloma

Who this might be right for
Myeloma
M.D. Anderson Cancer Center 79
Not applicableStudy completedNCT04367610
What this trial is testing

Effects of A Standardized Treatment Approach on Kidney Transplant Recipients With Antibody-Mediated Rejection

Who this might be right for
Antibody-mediated RejectionKidney Transplant RejectionGraft Loss
Istanbul University 75
Not applicableLooking for participantsNCT05968417
What this trial is testing

Myeloma Novel Drug Discovery Ver 1.2

Who this might be right for
Multiple Myeloma
Institute of Cancer Research, United Kingdom 250
Not applicableStudy completedNCT06030089
What this trial is testing

Plasma Dosage of Venetoclax in the Fup of AML Patients Treated With Aza + Ven

Who this might be right for
Acute Myeloid Leukemia
Centre Hospitalier Universitaire de Nice 20
Large-scale testing (Phase 3)Study completedNCT02181413
What this trial is testing

Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant

Who this might be right for
Multiple MyelomaAutologous Stem Cell Transplant
Takeda 656
Not applicableEnded earlyNCT01148160
What this trial is testing

Voriconazole Trough Plasma Levels : Genetic Polymorphism, Efficacy, Safety in Patients With Hematologic Malignancy

Who this might be right for
Invasive Fungal Infection
Asan Medical Center 10
Not applicableLooking for participantsNCT07470502
What this trial is testing

MICI-BIO: Study on Patient With Chronic Inflammatory Bowel Disease

Who this might be right for
IBD (Inflammatory Bowel Disease)
Meyer Children's Hospital IRCCS 15
Large-scale testing (Phase 3)UnknownNCT04000932
What this trial is testing

Platelet Rich Plasma in Carpal Tunnel Syndrome

Who this might be right for
Carpal Tunnel Syndrome
Baskent University 84
Not applicableStudy completedNCT00281801
What this trial is testing

Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Case Comprehensive Cancer Center 168
Testing effectiveness (Phase 2)Active Not RecruitingNCT04756401
What this trial is testing

Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refractory Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Academic and Community Cancer Research United 8
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07828522
What this trial is testing

F182112 in Combination With Isatuximab and Lenalidomide for the Treatment of Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)Transplant-eligible Patients
Institute of Hematology & Blood Diseases Hospital, China 10
Not applicableLooking for participantsNCT07785401
What this trial is testing

Efficacy of Platelet-Rich Plasma Added to Hyaluronic Acid in Knee Osteoarthritis

Who this might be right for
Knee OsteoarthritisKnee Osteoarthritis (Knee OA)Knee Osteoarthritis (OA)+1 more
Implai Sp z o.o 50
Early research (Phase 1)Study completedNCT01231919
What this trial is testing

MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Leukemias of Ambiguous LineageAcute Myeloid Leukemia/Transient Myeloproliferative Disorder+48 more
National Cancer Institute (NCI) 45
Not applicableUnknownNCT03082430
What this trial is testing

GO PRP: Assessing the Efficacy of Intra Articular Injection of Platelets Rich Plasma for Gonarthrosis Treatment in Routine Care

Who this might be right for
Knee Osteoarthritis
Hospital St. Joseph, Marseille, France 60
Not applicableLooking for participantsNCT06151730
What this trial is testing

Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study

Who this might be right for
Chronic Lymphocytic LeukemiaHematopoietic and Lymphoid System NeoplasmMantle Cell Lymphoma+2 more
Mayo Clinic 100
Early research (Phase 1)UnknownNCT05325801
What this trial is testing

CAR-T Cells Targeting Both BCMA and GPRC5D in Treatment of Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Zhejiang University 9
Testing effectiveness (Phase 2)Study completedNCT00884312
What this trial is testing

Extended Carfilzomib Therapy for Patients Previously Enrolled in Carfilzomib Treatment Protocols

Who this might be right for
Multiple MyelomaSolid Tumors
Amgen 101
Testing effectiveness (Phase 2)Active Not RecruitingNCT07217119
What this trial is testing

Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Feladilimab (GSK3359609) in Participants With RRMM

Who this might be right for
Multiple Myeloma
GlaxoSmithKline 25
Testing effectiveness (Phase 2)Study completedNCT01668719
What this trial is testing

S1211 Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma

Who this might be right for
DS Stage I Plasma Cell MyelomaDS Stage II Plasma Cell MyelomaDS Stage III Plasma Cell Myeloma
SWOG Cancer Research Network 142
Next Page